|

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

RECRUITINGN/ASponsored by University of California, San Francisco
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Francisco
Started2023-01-19
Est. completion2026-12-31
Eligibility
Age40 Years – 90 Years
Healthy vol.Accepted
Locations3 sites

Summary

Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation. The 10-week COPD Wellness and Plus+ Program directly addresses this gap, and yet, programs like these do not automatically lead to improved outcomes, which leads to the implementation of a Health Advocates program to address participant's social needs and barriers to healthcare.

Eligibility

Age: 40 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* Provision of signed and dated informed consent form
* Willingness to participate in the COPD Wellness program
* 40 to 90 years old
* English or Spanish speaking
* Physician-diagnosed COPD
* Spirometry-confirmed FEV1/FVC ratio \<= 0.7 and FEV1% predicted \<80% based on GLI-O prediction equation
* COPD Assessment Test ≥ 10 or history of 1+ exacerbation requiring hospitalization or 2+ outpatient exacerbations requiring steroid therapy
* Currently prescribed COPD medication(s)
* Ability to exercise with lower extremities
* No COPD exacerbations for ≥ 6 weeks
* Currently receiving care within SFHN

  * Note: Forced expiratory volume in the first second (FEV1); Forced vital capacity (FVC)

Exclusion Criteria:

* Pregnancy
* Dementia, cognitive impairment, or symptomatic psychiatric illness that would impair them from participating
* Unstable cardiovascular disease (includes recent \[\<6 months\] myocardial infarction or pulmonary embolism, uncontrolled arrhythmia, poorly controlled heart failure)
* Other severe co-morbidity which means exercise is contraindicated (screened by Registered Nurse in consultation with Pulmonologist)
* Transmittable pulmonary infection (tuberculosis, COVID19)
* Participated in pulmonary rehabilitation in the past 12-months
* COPD exacerbation in the past 6 weeks
* Activities restrictions that limit one's ability to engage in moderate physical activity
* Other diagnosis or condition that carry a prognosis of death within the next year

Conditions2

COPDCOPD - Chronic Obstructive Pulmonary Disease

Locations3 sites

Zuckerberg San Francisco General (ZSFG) Hospital
San Francisco, California, 94110
Neeta Thakur, MD, MPH628-206-8314neeta.thakur@ucsf.edu
Maxine Hall Health Center (MHHC)
San Francisco, California, 94115
Migdalia Ordonez, MD
Southeast Health Center (SEHC)
San Francisco, California, 94124
Keith Seidel, MD

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.